Carlsmed (CARL) Share-based Compensation (2024 - 2026)

Carlsmed (CARL) has reported Share-based Compensation for 3 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 12.85% year-over-year to $2.5 million; the trailing twelve-month figure through Jun 2026 stood at $2.5 million (up 12.85% YoY), and the FY2025 full-year result was $8.5 million, up 376.02% from the prior year.
• Share-based Compensation eased to $2.5 million in Q2 2026 per CARL's latest filing, from $2.5 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $3.1 million in Q3 2025 and bottomed at $52000.0 in Q2 2024.
• Historically, Share-based Compensation has averaged $1.3 million across 3 years, with a median of $790000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation soared 4639.26% in 2025, then gained 12.85% in 2026.
• Over 3 years, Share-based Compensation stood at $100000.0 in 2024, then jumped by 690.0% to $790000.0 in 2025, then soared by 215.85% to $2.5 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $2.5 million, $2.5 million, and $790000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.